AAVXF vs VRTX: Which Stock is Better?
Side-by-side comparison of Abivax S.A. and Vertex Pharmaceuticals Inc in 2026
AAVXF
Abivax S.A.
$115.65
VRTX
Vertex Pharmaceuticals Inc
$430.29
Key Metrics Comparison
| Metric | AAVXF | VRTX | Winner |
|---|---|---|---|
| Market Cap | $9.58B | $110.67B | VRTX |
| P/E Ratio | N/A | 28.40 | VRTX |
| EPS (TTM) | $N/A | $15.32 | VRTX |
| Revenue Growth | -0.6% | 0.1% | VRTX |
| Gross Margin | 100.0% | 53.7% | AAVXF |
Analyze AAVXF
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AAVXF or VRTX a better investment?
Comparing AAVXF and VRTX: Abivax S.A. has a market cap of $9.58B while Vertex Pharmaceuticals Inc has $110.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AAVXF and VRTX?
AAVXF (Abivax S.A.) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AAVXF or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AAVXF or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.6% for AAVXF.
Which company is more profitable: AAVXF or VRTX?
Abivax S.A. (AAVXF) has higher gross margins at 100.0% compared to 53.7% for VRTX.
Which is the larger company: AAVXF or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.67B compared to $9.58B for AAVXF.
Should I buy AAVXF or VRTX in 2026?
Both AAVXF and VRTX have investment merit. AAVXF trades at $115.65 while VRTX trades at $430.29. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AAVXF and VRTX stock?
Key differences: Market Cap ($9.58B vs $110.67B), P/E Ratio (N/A vs 28.4x), Revenue Growth (-0.6% vs 0.1%), Gross Margin (100.0% vs 53.7%).